We use cookies

Essential storage keeps the site working (sign-in, theme, this choice). We'd also like to load Google Analytics to understand, in aggregate, how the site is used — never your genetic data. See our Cookie Policy.

APOB rs2289037: Understanding This Common Genetic Variant

rs2289037
Trait
Limited evidenceGene: APOB

The rs2289037 variant is a common genetic change located within the APOB gene. It has been studied for its potential, albeit modest, associations with circulating lipid fractions in the blood.

What each genotype means

C/CLower attention

Typical lipid profile association

This genotype represents the most common form of this variant in many populations. Research suggests this variant in the APOB gene may have a modest influence on circulating lipid levels, though the overall impact on health remains limited and is not considered diagnostic.

This is the most frequent genotype, carried by the majority of individuals in European and East Asian populations.

C/TLower attention

Common variant carrier

Carrying one copy of the T allele is a common occurrence for this genetic marker. Studies have evaluated this polymorphism for potential modest effects on lipid fractions, but current evidence is limited and does not indicate a significant clinical risk on its own.

This genotype is present in approximately 15-25% of individuals within European and East Asian populations.

T/TLower attention

Less common variant carrier

This genotype represents the homozygous state for the less common allele at this position. While this variant has been studied for its association with lipid metabolism, the evidence for a strong clinical effect is limited, and it should not be used to predict individual health outcomes.

This genotype is the least common of the three, occurring at a lower frequency than the heterozygous state in most studied populations.

What is rs2289037 and Where is it Located?

The variant rs2289037 is a single nucleotide polymorphism (SNP) situated within the APOB gene on chromosome 2. In genetics, a SNP represents a variation at a single position in the DNA sequence among individuals. This specific variant is classified as a coding polymorphism, meaning it occurs in a region of the gene that provides instructions for building a protein. Because it is located within the APOB gene, researchers have long investigated whether this change might influence the structure or function of the resulting protein. While many SNPs have no observable effect on health, others are studied for their potential to contribute to complex traits, such as how the body processes fats and cholesterol. Scientists use large-scale genomic studies to determine if the presence of a specific allele at this location correlates with measurable differences in physiological markers across diverse groups of people.

The Role of the APOB Gene

The APOB gene provides the blueprint for apolipoprotein B, a critical protein involved in the transport of lipids throughout the body. This protein is a primary component of several types of lipoproteins, including chylomicrons and low-density lipoproteins (LDL), often referred to as 'bad' cholesterol. Apolipoprotein B acts as a structural scaffold for these particles and serves as a necessary ligand that allows them to bind to the LDL receptor, facilitating their clearance from the bloodstream. The gene produces two main isoforms: apoB-48, which is synthesized in the intestines, and apoB-100, which is produced in the liver. Because of its central role in lipid metabolism, variations in the APOB gene are frequently examined in the context of cardiovascular health and lipid-related conditions. Understanding how this gene functions is essential for interpreting how genetic variants might influence the balance of cholesterol and triglycerides in the blood.

Research Associations and Evidence Strength

The association between rs2289037 and lipid levels is considered to have limited evidence strength. While the variant has been evaluated in various genome-wide association studies (GWAS) and candidate gene studies, the observed effects on circulating lipid fractions are generally described as modest. In the context of complex traits like lipid levels, many genetic variants contribute only small, incremental changes, making it difficult to isolate the impact of a single SNP from the influence of other genetic factors, diet, and lifestyle. Current research suggests that while rs2289037 is a common marker, it does not appear to be a primary driver of severe lipid disorders. Instead, it is viewed as one of many genetic factors that may contribute to the natural variation in lipid profiles seen across the population. As with many common variants, the scientific consensus emphasizes that these associations are statistical in nature and do not necessarily imply a direct causal relationship with clinical health outcomes.

Population Frequency

The rs2289037 variant is a common missense polymorphism. It is observed in approximately 15-25% of individuals within European and East Asian populations, making it a relatively frequent genetic feature in these groups.

What You Can and Cannot Do With This Information

Genetic information regarding common variants like rs2289037 is primarily educational and intended to provide insight into the complexity of human genetics. It is important to understand that this information cannot be used to diagnose any medical condition or predict individual health outcomes. Because the association between this variant and lipid levels is modest and influenced by many other factors, it does not serve as a reliable tool for clinical decision-making. If you are concerned about your cholesterol levels or cardiovascular health, you should consult with a healthcare professional who can evaluate your overall health profile, including blood tests and family history. Never make changes to your diet, lifestyle, or medication regimen based on genetic data without first discussing it with your doctor or a qualified pharmacist. Genetic testing for common variants is not a substitute for professional medical advice and comprehensive clinical screening.

How common is this variant?

The rs2289037 variant is a common missense polymorphism present in 15-25% of European and East Asian populations.

Frequently asked questions

Is rs2289037 a cause of high cholesterol?

No, rs2289037 is not considered a direct cause of high cholesterol. It is a common genetic variant that has been statistically associated with modest differences in lipid levels, but it does not determine your cholesterol status on its own.

Should I be worried if I have the T allele for rs2289037?

There is no reason for concern based on this variant alone. It is a common genetic marker, and its presence does not provide enough information to assess your personal health risk or diagnose any condition.

Can I use this genetic information to change my diet?

You should not change your diet based on this genetic variant. Dietary decisions should be based on your overall health, blood lipid panels, and guidance from a healthcare provider or registered dietitian.

Where can I find more information about the APOB gene?

You can find reliable information about the APOB gene through resources like MedlinePlus Genetics or the National Center for Biotechnology Information (NCBI) Gene database. These sites provide comprehensive summaries of gene function and related health topics.

Sources & further reading

Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.

Curious what your genotype is for rs2289037?

Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.

Get my report — $29

Related variants in APOB